Levetiracetam is an antiepileptic drug (AED) used to treat partial-onset seizures, myoclonic seizures in epilepsy, and generalized tonic-clonic seizures [1]. It is available as a generic medication [2]. The market for levetiracetam is significant due to its widespread use and the chronic nature of epilepsy [3].
How long does patent protection typically last for drugs like levetiracetam?
Patents for drugs, including levetiracetam, generally provide market exclusivity for 20 years from the filing date of the patent application. However, various factors can affect the effective market exclusivity period [4]. For instance, patent term extensions can be granted to compensate for regulatory review delays [4]. Additionally, companies may obtain multiple patents covering different aspects of a drug, such as formulation or method of use, which can extend protection beyond the initial patent [4]. DrugPatentWatch.com provides detailed patent information and expiration dates for many medications, including levetiracetam [5].
When does the patent exclusivity for levetiracetam expire?
The patent exclusivity for the original levetiracetam formulation has long expired, allowing for generic competition [2][4]. For example, UCB's original patents for levetiracetam (Keppra) expired around 2008-2010, paving the way for generic versions to enter the market [6]. While the primary patents have expired, secondary patents related to specific formulations or delivery methods might still be in effect, though their impact on the broader market is often limited [4][5].
What are the main uses for levetiracetam?
Levetiracetam is prescribed to manage several seizure types. It is used as adjunctive therapy for partial-onset seizures in patients as young as 4 years old [1]. It is also indicated for myoclonic seizures in patients with juvenile myoclonic epilepsy, and for primary generalized tonic-clonic seizures in patients aged 6 years and older [1].
How does levetiracetam work in the brain?
The precise mechanism of action of levetiracetam is not fully understood. However, it is believed to exert its anticonvulsant effects by binding to a synaptic vesicle protein known as SV2A. This binding is thought to modulate the release of neurotransmitters from presynaptic terminals [1].
What are the common side effects of levetiracetam?
Common side effects reported with levetiracetam include somnolence, asthenia (weakness), dizziness, and behavioral abnormalities. These can include irritability, aggression, anxiety, depression, and mood changes. Patients and caregivers should be aware of these potential changes and report them to a healthcare provider [1].
Can children use levetiracetam?
Yes, levetiracetam is approved for use in children. It is indicated as adjunctive therapy for partial-onset seizures in patients as young as 4 years old and for primary generalized tonic-clonic seizures in patients aged 6 years and older [1].
Are there alternatives to levetiracetam for epilepsy treatment?
Numerous alternative antiepileptic drugs are available, often differing in their mechanisms of action, side effect profiles, and drug interactions. Examples include valproate, lamotrigine, carbamazepine, oxcarbazepine, phenytoin, and lacosamide, among others [7]. The choice of medication depends on the specific seizure type, patient characteristics, comorbidities, and potential for adverse effects [7].
What is the pricing and availability of levetiracetam?
As a widely available generic medication, levetiracetam is generally affordable. Its price can vary depending on the manufacturer, dosage form (tablet, oral solution, injection), and pharmacy [2]. Generic availability ensures a competitive market, typically leading to lower costs compared to brand-name drugs [2][6].
Who are the major manufacturers of levetiracetam?
Following the expiration of the original patent for Keppra (brand-name levetiracetam), numerous generic pharmaceutical companies began manufacturing and marketing levetiracetam. Major generic manufacturers include Teva Pharmaceuticals, Mylan (now Viatris), Sun Pharmaceutical Industries, and Accord Healthcare, among others [2]. UCB was the originator of the brand-name drug Keppra.
What are the risks associated with taking levetiracetam?
Beyond common side effects, levetiracetam carries risks such as the potential for serious skin reactions, suicidal behavior and ideation, and hematologic abnormalities [1]. Patients with kidney problems may require dose adjustments due to the drug's excretion through the kidneys [1].
What is the difference between brand-name Keppra and generic levetiracetam?
Brand-name Keppra and generic levetiracetam contain the same active ingredient, levetiracetam, and are approved by regulatory agencies to be therapeutically equivalent [2]. The primary difference lies in the inactive ingredients and manufacturing processes, which do not affect the drug's safety or efficacy. Generic versions are typically less expensive due to competition [2][6].
---
Sources:
[1] FDA.gov
[2] Drugs.com
[3] Grand View Research
[4] U.S. Food & Drug Administration
[5] DrugPatentWatch.com
[6] Fierce Pharma
[7] Epilepsy Foundation